Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

August 1, 2004

Older drugs' photoreactivity cataloged

Chicago - Tracking the photoreactivity of many medicines that predate U.S. Food and Drug Administration requirements in this area has been an inexact science, but it's becoming less so. That's because an extensive review released in a presentation at "Important Advances in Allergy-Immunology and Dermatology - From the Bench to the Bedside," a recent gathering of allergists, immunologists and dermatologists in Chicago hosted by Northwestern University, outlines photoreactivity data for more than 100 widely used drugs gleaned from more than 150 research articles